Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan E Bates

Showing results (91-100 of 293) with videos related to

Pageof 30
Sort By:
Seminars in Oncology|December 18, 2017
Metabolic symbiosis in cancer and its therapeutic implicationMark R Lipstein, Ipsita Pal, Susan E Bates, et al.
Cancer Research|April 17, 2004
A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue originsWilfred D Stein, Thomas Litman, Tito Fojo, et al.
Cancer Biology & Therapy|February 3, 2005
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapyRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
International Journal of Cancer|October 30, 2004
Differential expression of cell adhesion genes: implications for drug resistanceWilfred D Stein, Thomas Litman, Tito Fojo, et al.
The Oncologist|October 7, 2025
Highlights of ASCO 2025Brandon DaSilva, Alfred I Neugut, Tito Fojo, et al.
The Oncologist|October 2, 2008
Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantageWilfred D Stein, James Yang, Susan E Bates, et al.
Current Pharmaceutical Biotechnology|December 2, 2010
The challenge of exploiting ABCG2 in the clinicRobert W Robey, Caterina Ierano, Zhirong Zhan, et al.
Current Hematologic Malignancy Reports|June 25, 2019
Targeting Translation of mRNA as a Therapeutic Strategy in CancerIpsita Pal, Maryam Safari, Marko Jovanovic, et al.
Anti-Cancer Drugs|December 13, 2006
Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogeneticsJohn F Deeken, William D Figg, Susan E Bates, et al.
Seminars in Oncology|September 20, 2017
Current challenges in the management of breast cancer brain metastasesCiara C O'Sullivan, Nicole N Davarpanah, Jame Abraham, et al.
Pageof 30

Showing results (91-100 of 293) with videos related to

Sort By:
Pageof 30
Seminars in Oncology|December 18, 2017
Metabolic symbiosis in cancer and its therapeutic implicationMark R Lipstein, Ipsita Pal, Susan E Bates, et al.
Cancer Research|April 17, 2004
A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue originsWilfred D Stein, Thomas Litman, Tito Fojo, et al.
Cancer Biology & Therapy|February 3, 2005
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapyRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
International Journal of Cancer|October 30, 2004
Differential expression of cell adhesion genes: implications for drug resistanceWilfred D Stein, Thomas Litman, Tito Fojo, et al.
The Oncologist|October 7, 2025
Highlights of ASCO 2025Brandon DaSilva, Alfred I Neugut, Tito Fojo, et al.
The Oncologist|October 2, 2008
Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantageWilfred D Stein, James Yang, Susan E Bates, et al.
Current Pharmaceutical Biotechnology|December 2, 2010
The challenge of exploiting ABCG2 in the clinicRobert W Robey, Caterina Ierano, Zhirong Zhan, et al.
Current Hematologic Malignancy Reports|June 25, 2019
Targeting Translation of mRNA as a Therapeutic Strategy in CancerIpsita Pal, Maryam Safari, Marko Jovanovic, et al.
Anti-Cancer Drugs|December 13, 2006
Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogeneticsJohn F Deeken, William D Figg, Susan E Bates, et al.
Seminars in Oncology|September 20, 2017
Current challenges in the management of breast cancer brain metastasesCiara C O'Sullivan, Nicole N Davarpanah, Jame Abraham, et al.
Pageof 30